Compare NWPX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWPX | DNA |
|---|---|---|
| Founded | 1966 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.9M | 835.7M |
| IPO Year | 1996 | 2020 |
| Metric | NWPX | DNA |
|---|---|---|
| Price | $97.06 | $11.23 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 3 |
| Target Price | ★ $111.00 | $8.00 |
| AVG Volume (30 Days) | 108.5K | ★ 3.3M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.71 | ★ 46.49 |
| EPS | ★ 4.55 | N/A |
| Revenue | ★ $526,003,000.00 | $170,155,000.00 |
| Revenue This Year | $14.79 | N/A |
| Revenue Next Year | N/A | $13.05 |
| P/E Ratio | $36.60 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $53.15 | $5.37 |
| 52 Week High | $152.03 | $18.22 |
| Indicator | NWPX | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 51.48 |
| Support Level | $94.81 | $6.75 |
| Resistance Level | $114.37 | $11.14 |
| Average True Range (ATR) | 3.54 | 1.13 |
| MACD | 0.26 | 0.00 |
| Stochastic Oscillator | 22.40 | 36.99 |
NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products, and operates in two segments, Water Transmission Systems (WTS), operating as the Northwest Pipe Company brand, and Precast Infrastructure and Engineered Systems (Precast), which includes the brands NWPX Geneva and NWPX Park. WTS manufactures large-diameter, high-pressure steel pipeline systems for use in water infrastructure applications, which are related to drinking water systems. Precast manufactures stormwater and wastewater technology products, high-quality precast and reinforced concrete products, including reinforced concrete pipe (RCP), manholes, box culverts, vaults, and catch basins, pump lift stations, oil water separators, biofiltration units, and other environmental and engineered solutions.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.